Shanghai Kejin Biotechnology
High-quality disposable consumables for life science laboratories
About Shanghai Kejin Biotechnology
Shanghai Kejin Biotechnology Co., Ltd., operating under the brand Kirgen, is a high-tech enterprise founded in Shanghai in 2015. The company specializes in the research, development, production, and sale of disposable laboratory consumables. Kirgen has established itself as a manufacturer in the life sciences field, mastering new material technologies and polymer material modification to produce its product line.
The company's product portfolio is manufactured from medical-grade polypropylene using automated molding systems in a 100,000-grade clean environment to ensure products are DNase/RNase free and non-pyrogenic. Key product categories include pipette tips, robotic tips, centrifuge tubes, serological pipettes, cryogenic vials, and deep well plates, which are used for applications in molecular biology, cell culture and preservation, liquid handling, and in vitro diagnostics. Kirgen also offers OEM services to meet varied customer needs.
Operating on a global scale, Kirgen serves research institutions, medical organizations, clinical laboratories, and industrial units across the life science, pharmaceutical, and food safety sectors in over 65 countries. The company has an Asia Pacific headquarters in Shanghai to manage stock and logistics for the Greater China region and neighboring countries. It holds multiple certifications, including ISO 13485, ISO 9001, CE, and SFDA, underscoring its commitment to quality standards.
Source: Dealroom company dataAt a glance
- Status
- Operational
- Open positions
- None listed
- Dealroom signal
- 12.0/100
- Links
- Website
News
Open roles
Funding history
Company financing events and reported valuations.
| Deal type | Date | Amount | Valuation | Investors | Source |
|---|---|---|---|---|---|
| EARLY VC✓Equity / VC | May 2023 | $14M | $55M | Addor Capital · Industrial Securities Capital · Yaojin Capital | ↗ |
Growth signals
Latest recorded traffic for Shanghai Kejin Biotechnology is 50 monthly website visits, down 98.4% over the last three months.
Investments and acquisitions
Recent portfolio relationships for companies that also act as investors or acquirers.
Shanghai Kejin Biotechnology in its local ecosystem
The Shanghai Kejin Biotechnology office with the hot startups, most funded companies and investors around it. Hover or tap a pin.
Dealroom maps whole ecosystems like this one for cities, regions and governments. See the ecosystem platform →
Investors
From Dealroom's funding and investor records, grouped by the round each investor first entered.
Series A3 investors entered at this stage
Addor Capital
Industrial Securities Capital- YCYaojin Capital
Source: Dealroom Talent Intelligence.
Global footprint
Market sentiment
An AI-synthesised read of the highest-engagement posts about Shanghai Kejin Biotechnology on X, ranked by likes and reposts, corporate channels excluded.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See Shanghai Kejin Biotechnology’s full profile on Dealroom
Request a free trial to see the complete deal history, financials, people graph and growth signals.
Takes under a minute. Already use Dealroom? Log in.